OMDA
Omada Health·NASDAQ
--
--(--)
--
--(--)
5.40 / 10
Netural
Analyst consensus is overwhelmingly bullish (83% Buy, 17% Strong Buy) despite a 19.9% price decline. Fund‑flow score is 7.65/10 with positive inflows across all block sizes. Sentiment remains neutral, reflecting mixed market sentiment.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
17%
Buy
83%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-06
InstitutionMorgan Stanley
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for OMDA?
- OMDA holds a Bearish analyst rating, with 83% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.40/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
